Literature DB >> 2829929

Effect of synthetic calcium pyrophosphate and hydroxyapatite crystals on the interaction of human blood mononuclear cells with chondrocytes, synovial cells, and fibroblasts.

J M Dayer1, V Evêquoz, C Zavadil-Grob, M D Grynpas, P T Cheng, J Schnyder, U Trechsel, H Fleisch.   

Abstract

Synthetic calcium pyrophosphate dihydrate crystals and, to a lesser extent, synthetic hydroxyapatite crystals increased the amount of interleukin-1/mononuclear cell factor released by human blood monocytes, as measured by collagenase and prostaglandin E2 production by rabbit chondrocytes, human dermal fibroblasts, and adherent rheumatoid synovial cells. The same crystals also directly induced collagenase and prostaglandin E2 secretion by rabbit chondrocytes, and potentiated the action of interleukin-1/mononuclear cell factor on chondrocytes. These mechanisms may be important in the pathogenesis of the destructive arthropathies associated with these crystals.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2829929     DOI: 10.1002/art.1780301208

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  11 in total

Review 1.  The role of crystals in articular tissue degeneration.

Authors:  H S Cheung
Journal:  Curr Rheumatol Rep       Date:  1999-12       Impact factor: 4.592

Review 2.  Update on colchicine, 2017.

Authors:  Anastasia Slobodnick; Binita Shah; Svetlana Krasnokutsky; Michael H Pillinger
Journal:  Rheumatology (Oxford)       Date:  2018-01-01       Impact factor: 7.580

3.  Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis.

Authors:  P A Guerne; B L Zuraw; J H Vaughan; D A Carson; M Lotz
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

4.  Synovial fluid hydroxyapatite crystals: detection thresholds of two methods.

Authors:  T Cunningham; D Uebelhart; J M Very; G H Fallet; T L Vischer
Journal:  Ann Rheum Dis       Date:  1989-10       Impact factor: 19.103

Review 5.  How can calcium pyrophosphate crystals induce inflammation in hypophosphatasia or chronic inflammatory joint diseases?

Authors:  C Beck; H Morbach; P Richl; M Stenzel; H J Girschick
Journal:  Rheumatol Int       Date:  2008-09-28       Impact factor: 2.631

6.  Crystal-neutrophil interactions lead to interleukin-1 synthesis.

Authors:  C J Roberge; J Grassi; R De Médicis; Y Frobert; A Lussier; P H Naccache; P E Poubelle
Journal:  Agents Actions       Date:  1991-09

Review 7.  Hydroxyapatite deposition disease of the joint.

Authors:  Eamonn S Molloy; Geraldine M McCarthy
Journal:  Curr Rheumatol Rep       Date:  2003-06       Impact factor: 4.592

8.  Chondroprotective action of salmon calcitonin in experimental arthropathies.

Authors:  J E Badurski; W Schwamm; J Popko; L Zimnoch; F Rogowski; J Pawlica
Journal:  Calcif Tissue Int       Date:  1991-07       Impact factor: 4.333

9.  Octacalcium phosphate crystals directly stimulate expression of inducible nitric oxide synthase through p38 and JNK mitogen-activated protein kinases in articular chondrocytes.

Authors:  Hang-Korng Ea; Benjamin Uzan; Christian Rey; Frédéric Lioté
Journal:  Arthritis Res Ther       Date:  2005-05-27       Impact factor: 5.156

Review 10.  The role of Interleukin-1 receptor antagonist as a treatment option in calcium pyrophosphate crystal deposition disease.

Authors:  Alberto Altomare; Addolorata Corrado; Nicola Maruotti; Daniela Cici; Francesco Paolo Cantatore
Journal:  Mol Biol Rep       Date:  2021-06-01       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.